ArticleJournal of neurology2022

Anti-CD20 immunotherapy in progressive multiple sclerosis: 2-year real-world follow-up of 108 patients.

Maximilian Einsiedler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.